NIH awards $12 million to develop antiviral therapies

NIH awards $12 million to develop antiviral therapies

The National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, recently awarded more than $12 million to three institutions for the development of antiviral therapies to treat diseases caused by viruses with pandemic...